We've talked the medical innovation talk many times -- sometimes here on LillyPad, and more often from the mouth of our CEO, John Lechleiter, who evangelizes on behalf of the industry about the need for an "innovation ecosystem."
On Thursday, some fresh voices in Washington, D.C., will take their turn. Lilly, along with the Campaign for Modern Medicines, is sponsoring a Washington Post Live conference called "Advancing Medical Innovation." Our future challenges, of course, are significant: Alzheimer's disease is an emerging medical and financial crisis, and diabetes continues to relentlessly attack our global communities, including younger people.
Addressing these oncoming medical tsunamis -- and pathways to better treatments -- is an important step toward finding solutions. Washington Post Live has recruited an A Team of medical and scientific experts to talk about our environmental needs, including Congressman John Dingell of Michigan, Stephen Spielberg, deputy commissioner at the U.S. Food and Drug Administration, and George Vrandenburg, founder of USAgainstAlzheimer's.
Francis Collins, director of the National Institutes of Health, will deliver a keynote address entitled "Triumphs and Challenges at the World's Largest Supporter of Biomedical Research," and Mark Shriver will talk about his father, Sargent Shriver, and his battle against Alzheimer's disease.
These speakers and other panels (such as the one addressing scientific literacy) will look not only at our emerging medical crises, but our best path toward success. In the same way that diabetes has become more manageable over the last century and the death rate from AIDS has dropped significantly, we must find solutions to diseases such as Alzheimer's. It should be a fascinating morning, and we hope you can make it.